Startups

biotx.ai logo

biotx.ai

biotx.ai develops causal AI and human-genetics analysis tools for drug discovery. It applies Mendelian randomization, colocalization and machine learning to genetic, disease and biomarker data to evaluate drug targets and estimate associations with clinical development outcomes. Its data and models are intended to help researchers prioritize targets and design clinical trials.

Team

Charles RavaraniCTO and Board Member
Hannes BaukmannSenior Data Scientist
Harald PingerBoard Member
Hussein KanjiBoard Member
James SullivanSenior Data Scientist
Justin CopeSenior Machine Learning Engineer
Jörn KlingerCo-Founder
Kevin MishkinBoard Member
Luis SeibertData Scientist
Marco SchmidtCEO and Board Member
Margaretha LamparterBioinformatician
Marius ArendSenior Computational Biologist
Radi HilanehData Analyst
Roman FudimHead of Translational Science

Investments

$—Unknown dateOcama Partners